COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 803: Articles 8021-8030  | Next

Adherence to and enforcement of non-pharmaceutical interventions (NPIs) for COVID-19 prevention in Nigeria, Rwanda, and Zambia: A mixed-methods analysis
Solomon, H., Thea, D. M., Galea, S., Sabin, L. L., Lucey, D. R., Hamer, D. H.
10.1101/2022.03.29.22273120 — Posted: 2022-03-30
Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland
Ahava, M. J., Jarva, H., Jääskeläinen, A. J., Lappalainen, M. J., Vapalahti, O., Kurkela, S.
10.1101/2022.03.25.22272952 — Posted: 2022-03-30
Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu
Petrone, M. E., Lucas, C., Menasche, B., Breban, M. I., Yildirim, I., Campbell, M., Omer, S. B., Ko, A., Grubaugh, N., Iwasaki, A., Wilen, C. B., Vogels, C. B. F., Fauver, J. R.
10.1101/2022.03.28.22273077 — Posted: 2022-03-30
Healthcare workers perceptions and medically approved COVID-19 infection risk: understanding the mental health dimension of the pandemic. A German hospital case study
Kuhlmann, E., Behrens, G., Cossmann, A., Homann, S., Happle, C., Dopfer-Jablonka, A.
10.1101/2022.03.28.22273029 — Posted: 2022-03-30
Labor market position and depression during the COVID-19 epidemic among young adults (18 to 30 years): a nationally representative study in France.
Melchior, M., Florence, A.-M., Davisse-Paturet, C., Falissard, B., Galera, C., Hazo, J.-B., Vuillermoz, C., WARSZAWSKI, J., Dione, F., Rouquette, A.
10.1101/2022.03.25.22272948 — Posted: 2022-03-30
Substance use and associated factors among Adolescents during the Covid-19 pandemic in Eastern Ethiopia: A cross-sectional study
Zerihun, E., Tesama, k.
10.1101/2022.03.29.22273151 — Posted: 2022-03-30
Unravelling the link between sleep and mental health during the COVID-19 pandemic
Gonzalez-Hijon, J., Kähler, A. K., Frans, E. M., Valdimarsdottir, U. A., Sullivan, P. F., Fang, F., Lovik, A.
10.1101/2022.03.28.22273027 — Posted: 2022-03-30
Endemicity is not a victory: the unmitigated downside risks of widespread SARS-CoV-2 transmission
Stoddard, M., Novokhodko, A., Sarkar, S., Van Egeren, D., White, L. F., Hochberg, N. S., Rogers, M., Zetter, B., Joseph-McCarthy, D., Chakravarty, A.
10.1101/2022.03.29.22273146 — Posted: 2022-03-30
COVID-19 mortality among working-age Americans in 46 states, by industry and occupation
Chen, Y.-H., Chen, R., Charpignon, M.-L., Kiang, M. V., Riley, A. R., Glymour, M. M. M., Bibbins-Domingo, K., Stokes, A. C.
10.1101/2022.03.29.22273085 — Posted: 2022-03-30
Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative
Butler-Laporte, G., Povysil, G., Kosmicki, J., Cirulli, E. T., Drivas, T., Furini, S., Saad, C., Schmidt, A., Olszewski, P., Quinodoz, M., Celik, E., Kundu, K., Walter, K., Jung, J., Stockwell, A. D., Sloofman, L. G., Charney, A. W., Jordan, D., Beckmann, N., Przychodzen, B., Chang, T., Pottinger, T. D., Shang, N., Brand, F., Fava, F., Mari, F., Chwialkowska, K., Niemira, M., Korotko, U., Pula, S., Baillie, J. K., Stuckey, A., Ganna, A., Karczewski, K. J., Veerapen, K., Bourgey, M., Bourque, G., Eveleigh, R. J., Forgetta, V., Morrison, D., Langlais, D., Lathrop, M., Mooser, V., Nakanishi, T., Frithiof, R., Hultstrom, M., Lipcsey, M., Marincevic-Zuniga, Y., Nordlund, J., Schiabor Barrett, K. M., Bolze, A., White, S., Riffle, S., Tanudjaja, F., Sandoval, E., Neveux, I., Dabe, S., Casadei, N., Motameny, S., Alaamery, M., Massadeh, S., Aljawini, N., Almutairi, M. S., Arab, Y. M., Alqahtan, S. A., Al Harthi, F. S., Almutairi, A., Alqubaishi, F., Alotaibi, S., Binowayn, A., Alsolm, E. A., El Bardisy, H., Fawzy, M., COVID-19 Host Genetics Initiative, , DeCOI Host Genetics Group, , GEN-COVID Multicenter Study, , GenOMICC Consortium, , Japan COVID-19 Task Force, , Regeneron Genetics Center, , Geschwind, D. H., Arteaga, S., Stephens, A., Butte, M. J., Boutros, P. C., Yamaguchi, T. N., Tao, S., Eng, S., Sanders, T., Tung, P. J., Broudy, M. E., Pan, Y., Gonzalez, A., Chavan, N., Johnson, R., Pasaniuc, B., Yaspan, B., Smieszek, S., Rivolta, C., Bibert, S., Bochud, P.-Y., Dabrowski, M., Zawadzki, P., Sypniewski, M., Kaja, E., Chariyavilaskul, P., Nilaratanakul, V., Hirankarn, N., Shotelersuk, V., Pongpanich, M., Phokaew, C., Chetruengchai, W., Kawai, Y., Hasegawa, T., Naito, T., Namkoong, H., Edahiro, R., Kimura, A., Ogawa, S., Kanai, T., Fukunaga, K., Okada, Y., Imoto, S., Miyano, S., Mangul, S., Abedalthagafi, M. S., Zeberg, H., Grzymski, J. J., Washington, N. L., Ossowski, S., Ludwig, K. U., Schulte, E. C., Riess, O., Moniuszko, M., Kwasniewski, M., Mbarek, H., Ismail, S. I., Verma, A., Goldstein, D. B., Kiryluk, K., Renieri, A., Ferreira, M., Richards, J. B.
10.1101/2022.03.28.22273040 — Posted: 2022-03-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).